USC.edu
Are You a Patient?

Andrew Doan

Clinical Associate Professor of Pediatrics (Practitioner)

Image of Andrew Doan
Is this your profile? Click to edit
Email [email protected]
CTSI Profile

Publications

  • Ixazomib with chemotherapy for childhood relapsed acute lymphoblastic leukemia: a TACL consortium report. Blood Neoplasia. 2026 Aug; 3(3):100247.. View in PubMed
  • Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826. J Clin Oncol. 2026 Feb 20; 44(6):449-454.. View in PubMed
  • Optical Genome Mapping in Pediatric Hematologic Malignancies: High Diagnostic Yield and Unique Insights Across Leukemia Subtypes. Mod Pathol. 2026 Jan; 39(1):100937.. View in PubMed
  • T-cell dysfunction during blinatumomab therapy in pediatric acute lymphoblastic leukemia. Blood Adv. 2025 Aug 12; 9(15):3689-3693.. View in PubMed
  • Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma. N Engl J Med. 2024 10 17; 391(15):1379-1389.. View in PubMed
  • COVID-19 vaccinated children, adolescents, and young adults with acute lymphoblastic leukemia show spike reactive antibodies and multifunctional T-cells. Int J Cancer. 2024 12 15; 155(12):2190-2200.. View in PubMed
  • IKZF1PLUS alterations contribute to outcome disparities in Hispanic/Latino children with B-lymphoblastic leukemia. Pediatr Blood Cancer. 2024 Jul; 71(7):e30996.. View in PubMed
  • Loss-of-function OGFRL1 variants identified in autosomal recessive cherubism families. JBMR Plus. 2024 Jun; 8(6):ziae050.. View in PubMed
  • Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic Leukemia in an Academic Clinical Laboratory. J Mol Diagn. 2024 01; 26(1):49-60.. View in PubMed
  • Efficacy and safety of FLAG-IDA as front-line therapy in de novo paediatric acute myeloid leukaemia population. Br J Haematol. 2023 07; 202(1):e3-e6.. View in PubMed

Similar People